Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

BACKGROUND: South Africa has a high burden of rifampicin-resistant tuberculosis (including multidrug-resistant [MDR] tuberculosis), with increasing rifampicin-monoresistant (RMR) tuberculosis over time. Resistance acquisition during first-line tuberculosis treatment could be a key contributor to thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Helen, Salaam-Dreyer, Zubeida, Goig, Galo A, Nicol, Mark P, Menardo, Fabrizio, Dippenaar, Anzaan, Mohr-Holland, Erika, Daniels, Johnny, Cudahy, Patrick G T, Borrell, Sonia, Reinhard, Miriam, Doetsch, Anna, Beisel, Christian, Reuter, Anja, Furin, Jennifer, Gagneux, Sebastien, Warren, Robin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563432/
https://www.ncbi.nlm.nih.gov/pubmed/34766068
http://dx.doi.org/10.1016/S2666-5247(21)00144-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563432/
https://www.ncbi.nlm.nih.gov/pubmed/34766068
http://dx.doi.org/10.1016/S2666-5247(21)00144-0

Ejemplares similares